Report Germany - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Germany - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Germany: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Germany

The German market for other medicaments for therapeutic or prophylactic uses soared to $X in 2022, rising by X% against the previous year. Overall, consumption posted a buoyant increase. Over the period under review, the market reached the maximum level in 2022 and is expected to retain growth in the near future.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Germany

In value terms, production of other medicaments for therapeutic or prophylactic uses amounted to $X in 2022 estimated in export price. Over the period under review, production, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2018 with an increase of X% against the previous year. Production of peaked at $X in 2020; afterwards, it flattened through to 2022.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Germany

Exports of other medicaments for therapeutic or prophylactic uses from Germany skyrocketed to X tons in 2022, picking up by X% against 2021. In general, exports posted modest growth. The pace of growth was the most pronounced in 2017 with an increase of X% against the previous year. The exports peaked at X tons in 2018; however, from 2019 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses declined to $X in 2022. Over the period under review, exports recorded a pronounced increase. The pace of growth was the most pronounced in 2017 when exports increased by X%. Over the period under review, the exports of hit record highs at $X in 2018; however, from 2019 to 2022, the exports remained at a lower figure.

Exports by Country

Belgium (X tons), Brazil (X tons) and China (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Germany, with a combined X% share of total exports. The Netherlands, France, Switzerland, Turkey, Italy, the United States, Ireland, Australia, Spain and Egypt lagged somewhat behind, together accounting for a further X%.

From 2012 to 2022, the biggest increases were recorded for Ireland (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest markets for other medicaments for therapeutic or prophylactic uses exported from Germany were Ireland ($X), China ($X) and the Netherlands ($X), together comprising X% of total exports.

Ireland, with a CAGR of X%, saw the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, declining by X% against the previous year. In general, the export price, however, posted a modest expansion. The most prominent rate of growth was recorded in 2017 when the average export price increased by X%. Over the period under review, the average export prices attained the peak figure at $X per ton in 2018; however, from 2019 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Ireland ($X per ton), while the average price for exports to Australia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Ireland (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Germany

In 2022, the amount of other medicaments for therapeutic or prophylactic uses imported into Germany skyrocketed to X tons, jumping by X% on 2021. Over the period under review, imports showed a significant expansion. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, imports of other medicaments for therapeutic or prophylactic uses surged to $X in 2022. In general, imports recorded a prominent expansion. The pace of growth appeared the most rapid in 2014 when imports increased by X%. Over the period under review, imports of attained the maximum in 2022 and are expected to retain growth in years to come.

Imports by Country

In 2022, Belgium (X tons) was the main supplier of other medicaments for therapeutic or prophylactic uses to Germany, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Belgium exceeded the figures recorded by the second-largest supplier, India (X tons), more than tenfold. The third position in this ranking was taken by Switzerland (X tons), with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Belgium amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: India (X% per year) and Switzerland (X% per year).

In value terms, the United States ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Germany, comprising X% of total imports. The second position in the ranking was taken by Belgium ($X), with a X% share of total imports. It was followed by Switzerland, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from the United States totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Belgium (X% per year) and Switzerland (X% per year).

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, waning by X% against the previous year. Overall, the import price saw a deep contraction. The most prominent rate of growth was recorded in 2014 an increase of X%. The import price peaked at $X per ton in 2021, and then dropped remarkably in the following year.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($X,166 per ton), while the price for Belgium ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

China remains the largest other medicaments for therapeutic or prophylactic uses consuming country worldwide, accounting for 34% of total volume. Moreover, consumption of other medicaments for therapeutic or prophylactic uses in China exceeded the figures recorded by the second-largest consumer, India, threefold. The third position in this ranking was occupied by the United States, with an 8.1% share.
The country with the largest volume of production of other medicaments for therapeutic or prophylactic uses was China, accounting for 37% of total volume. Moreover, production of other medicaments for therapeutic or prophylactic uses in China exceeded the figures recorded by the second-largest producer, India, threefold. The third position in this ranking was occupied by the United States, with a 9.9% share.
In value terms, the United States constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Germany, comprising 80% of total imports. The second position in the ranking was occupied by Switzerland, with a 7.6% share of total imports. It was followed by Spain, with a 2.9% share.
In value terms, Ireland remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Germany, comprising 28% of total exports. The second position in the ranking was occupied by the United States, with an 11% share of total exports. It was followed by Switzerland, with an 8.4% share.
In 2020, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $167,940 per ton, rising by 20% against the previous year.
In 2020, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $72,183 per ton, with an increase of 48% against the previous year.

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Germany. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS

Country coverage:

  • Germany

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Germany
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) - Germany